, as well as overt nephropathy [2] in Japanese Type II diabetic patients. We examined whether b 3 -AR Trp64Arg contributes to the predisposition to microalbuminuria or overt proteinuria or both in a large group of Caucasian patients with Type II diabetes. During a period of 6 months, each day, on average the first 10 Type II diabetic patients attending the Outpatient Clinic for Diabetic Patients in Zabrze, residents of Zabrze, were screened for microalbuminuria (as repeated measurements of albumin : creatinine ratio [ACR] in random urine samples). Determination of renal status was based on the criteria proposed previously [3] and careful review of medical records. In total, 941 patients with established nephropathy and retinopathy status were collected [4] . From that group, 126 patients with overt proteinuria or chronic renal failure (CRF), 330 microalbuminuric patients, and a control group of 249 normoalbuminuric patients with at least 10 years of known diabetes duration were selected for the case-control comparisons and were genotyped at the b 3 -AR Trp64Arg locus. The overall frequency of the Arg allele was 9.3 %, which is comparable to that observed in other Caucasian samples but lower than that among the Japanese and Pima Indians. We observed no significant differences in genotype distributions, as well as allele frequencies between patients with normoalbuminuria, microalbuminuria or macroalbuminuria (Table 1) .
Recently, Sakane et al. found an increased frequency of the homozygous Arg/Arg genotype among 62 overt proteinuric Japanese Type II diabetic patients (5 Arg/Arg carriers, 57 noncarriers), compared with 176 normoalbuminuric control subjects (4/172) [2] . The authors concluded, that the presence of a homozygous genotype was a clinically useful marker for the increased risk of the development of diabetic nephropathy. Caution should be used, however, in the interpretation of these findings.
Letters
Corresponding author: W. Grzeszczak, Department and Clinic of Internal Medicine and Diabetology, Silesian School of Medicine, 3-go Maja 13±15, 41-800 Zabrze, Poland Firstly, in a previous study, the same group reported association between the b 3 -AR Trp64Arg locus and proliferative diabetic retinopathy [1] . When selecting cases for the association study with diabetic nephropathy, the authors stated that diabetic nephropathy was defined by a urinary albumin concentration of 300 mg/ml or more or end-stage renal failure with retinopathy. From that, it is not possible to tell whether the presence of retinopathy was used by the authors to define nephropathy in all patients with proteinuria or only in patients with end-stage renal disease. In any event not allowing to distinguish whether association with nephropathy or retinopathy was detected was an obvious confounder. The magnitude of the effect cannot be assessed as no data on the proportion of patients with end-stage renal disease were shown. Also, the increased frequency of Arg/Arg homozygotes was not seen in the microalbuminuria group, where the presence of retinopathy was not the inclusion criterion. Similarly, the association between the 64Arg allele and log (creatinine clearance) could have been confounded by retinopathy: if biased selection of cases with retinopathy was responsible for the excess of Arg/Arg homozygotes in the overt nephropathy group and, obviously, creatinine clearance was also lower in that group, ªspuriousº association might have been observed. Also, when using a case-control design, falsepositive association can occur as a result of population stratification and that can be minimized, for example, by random selection of subjects and control subjects from the same homogenous, large group of patients, as done in our study [4] . Sakane et al. did not clearly describe the original population, from which cases and controls were selected or give precise details of their method of sampling [2] .
Secondly, Sakane et al. used the values of urinary albumin concentration (UAC) to determine renal status in the study patients. If albumin excretion rate is, however, not measured as 24 hour or minute excretion albumin concentration for urinary creatinine concentration should be adjusted [3] .
Lastly, the impact of b 3 -AR Trp64Arg polymorphism on the overall risk of the development of nephropathy in Type II diabetic patients, if any, is rather small and is confined only to Arg/Arg homozygotes. Among 328 patients analysed by Sakane et al. [2] , only 14 (4.3 %) were carriers of the Arg allele on both chromosomes and, among them, 4 patients still had normoalbuminuria. If the data of Sakane et al. [2] is presented as the risk of overt nephropathy attributed to the homozygosity for the Arg allele, an odds ratio of 3.77 results, with a wide 95 % confidence interval from 0.98 to 14.53.
In conclusion, b 3 -AR Trp64Arg polymorphism is not associated with microalbuminuria or overt proteinuria in Caucasian Type II diabetic patients.
Sincerely, W. Grzeszczak, W. Saucha, M. J. Zychma, E. Zukowska-Szczechowska, B. Labuz, B. Lacka, I. Szydlowska data presented as means ± SD or median and quartiles; P -values for ANOVA, Kruskall-Wallis or chi-squared test a P < 0.001 b P < 0.01 c P < 0.05
